Guys today's presentation at 3PM is Important. GVAX- 60% INCREASE in survival + In addition, the IPI/GVAX Pancreas combination demonstrated an increase in one year survival, from 7 percent to 27 percent will proved as underdog for BPAX. May change the future of this company. The fact is Hopkins confirms the data and not BPAX.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.